Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer
2021 ◽
2019 ◽
Vol 26
(5)
◽
pp. 1105-1113
◽
2017 ◽
Keyword(s):
2014 ◽
Vol 145
(2)
◽
pp. 503-511
◽
2017 ◽
Vol 163
(2)
◽
pp. 255-262
◽